Loading clinical trials...
Loading clinical trials...
Pulmonary fibrosis (PF) results from a diverse group of health conditions and affects the lives of patients (including those who are post lung transplant), caregivers and family members. The Pulmonary...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pulmonary Fibrosis Foundation
Collaborators
NCT07615504 · Interstitial Lung Disease (ILD)
NCT05842681 · Idiopathic Pulmonary Fibrosis
NCT07572383 · Interstitial Lung Disease, Pulmonary Fibrosis
NCT03478826 · Interstitial Lung Disease
NCT06951217 · Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
Pulmonary Fibrosis Foundation
Chicago, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions